Lin is a member of the firm’s Intellectual Property and Technology Practice Group. His practice includes patent prosecution, opinions, licensing, and post-grant proceedings pertaining to biotechnology, pharmaceuticals, chemistry, material science, and medical devices. Lin focuses on efficient and effective patent procurement for universities, start-up companies, and mid-size companies.
Lin began his career as an academic scientist. He performed research in biochemistry, biophysics, physiology, and pharmacology at medical schools and universities in the U.S., Germany, and Austria, and worked in grant review administration at the National Institutes of Health. His legal practice has included work at a major biotechnology company and at general practice and IP boutique law firms.
- Tulane University, BS in Biology, summa cum laude, 1975
- Vanderbilt University, PhD in Molecular Biology, National Science Foundation Graduate Fellowship, 1982
- Georgetown University Law Center, JD, 2001
- U.S. Patent and Trademark Office
- American Intellectual Property Association
- Boston Bar Association
- Boston Patent Law Association, Chemical Practice Committee, Co-Chair, 2011-2014
- Biotechnology, including proteins and nucleic acids for therapy and diagnosis, antibodies, nutritional biochemistry, lipids, peptides, cell culture, cancer genetics, vaccines, microscopy, chromatography, and protein purification.
- Medical diagnostics, including cancer diagnostics, FISH, and ELISA.
- Pharmacology, including small molecule drugs, imaging agents, drug formulations, and drug delivery vehicles.
- Chemistry, including polymers, textiles, catalysts, biofuels, and antimicrobials
- Materials, including nanomaterials, semiconductor materials, magnetic materials, elastic materials.
- Devices, including cardiovascular devices, optical devices, microfluidic devices, fuel cells, nanoelectronic devices, batteries, and photovoltaic devices.